The intergroup/RTOG 85-01 concurrent chemoradiation regimen for Japanese esophageal cancer

Hepato-Gastroenterology

Volumn 53, Issue 72, 2006, Pages 863-868

  Yamashita, Hideomi ^a   Nakagawa, Keiichi ^a   Tago, Masao ^a   Nakamura, Naoki ^a   Shiraishi, Kenshiro ^a   Mafune, Ken Ichi ^a   Kaminishi, Michio ^a   Ohtomo, Kuni ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Chemoradiation; Chemotherapy; Esophageal cancer; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL; NEDAPLATIN;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; ESOPHAGITIS; ESOPHAGUS CANCER; ESOPHAGUS STENOSIS; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; HYDRATION; KIDNEY DISEASE; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; SEPTIC SHOCK; TREATMENT OUTCOME; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC PROTOCOLS; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY, HIGH-ENERGY; SURVIVAL ANALYSIS; UNITED STATES;

EID: 33845225387     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Araujo CM, Souhami L, Gil RA, et al: A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 1991; 67:2258-2261.
2. Herskovic A, Martz K, al-Sarraf M, et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. New Engl J Med 1992; 326:1593-1598.
3. Cooper JS, Guo MD, Herskovic A, et al: Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85101). Radiation Therapy Oncology Group. JAMA 1999; 281:1623-1627.
4. Smith TJ, Ryan LM, Douglass HO Jr, et al: Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 1998; 42:269-276.
5. Rebecca W, Richard M: Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev 2001; (2):CD002092.
6. Update in: Cochrane Database Syst Rev 2003; (1):CD 002092.
7. Albertsson M: A randomised Phase III clinical trial comparing surgery alone with chemoradiotherapy alone for localised resectable carcinoma of the esophagus. Stockholm: Oncologic Center, 2000.
8. Murakami M, Kuroda Y, Nakajima T, et al: Comparison between chemoradiation protocol intended for organ preservation and conventional surgery for clinical Tl-2 esophageal carcinoma. Int J Radiat Oncol Biol Phys 1999; 45:277-284.
9. Ohtsu A, Boku N, Muro K, et al: Definitive chemoradiotherapy for T4 and/or M1 lymphnode squamous cell carcinoma of the esophagus. J Clin Oncol 1999; 17:2915-2921.
10. Coia LR, Engstrom PF, Paul AR, et al: Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991; 20:29-36.
11. Jeremic B, Shibamoto Y, Acimovic L, et al: Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus. A phase II study. Int J Radiat Oncol Biol Phys 1998; 40:1061-1066.
12. Minsky BD, Neuberg D, Kelsen DP, et al: Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 1999; 43:517-523.
13. Itou Y, Fuwa N, Matsumoto A, et al: Concurrent chemoradiotherapy using protracted infusion of low-dose CDDP and 5-FU and radiotherapy for esophageal cancer. Nippon Igaku Hoshasen Gakkai Zasshi 1999; 59(8):395-401.
14. Hsu CH, Yeh KH, Lui LT, et al: Concurrent chemoradiotherapy for locally advanced esophageal cancer - a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil. Anticancer Res 1999; 19:4463-4467.
15. Nemoto K, Ogawa Y, Matsushita H, et al: A pilot study of radiation therapy comhined with daily low-dose cisplatin for esophageal cancer. Oncol Rep 2001; 8:785-789
16. Nabeya Y, Ochiai T: Chemotherapy for esophageal cancer. Gan To Kagaku Ryoho 2003; 30(12):1873-1880.
17. Terashima M, Ikeda K, Kawamura S, et al: Preclinical evaluation of several cisplatinum analogs against human esophageal carcinoma by subrenal capsule assay. Gan To Kagaku Ryoho 1990; 17(2):269-273.
18. Taguchi T, Wakui A, Nabeya K, et al: A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group, Gan To Kagaku Ryoho 1992; 19(4):483-488.
19. Yamanaka H, Motohiro T, Michiura T, et al: Nedaplatin and 5-FU combined with radiation in the treatment for esophageal cancer. Jpn J Thorac Cardiovasc Surg 1998; 46(10):943-948.
20. Yoshioka T, Gamoh M, Shineha R, et al: A new combination chemotherapy with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for advanced esophageal cancers. Intern Med 1999; 38(11):844-848.
21. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 1981; 47:207-214.
22. National Cancer Institute Common Toxicity Criteria (NCICTC) Version 2.0, April 1999; 30.
23. Ohtsu A, Yoshida S, Boku N, et al: Concurrent chemotherapy and radiation therapy for locally advanced carcinoma of the esophagus. Jpn J Clin Oncol 1995; 25:261-266.
24. Minsky BD, Pajak TF, Ginsberg RJ, et al: INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002; 20:1167-1174.
25. Forastiere AA, Orringer MB, Perez-Tamayo C: Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: Final report. J Clin Oncol 1993; 11:1118-1123.